{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:11:50Z","timestamp":1762506710047,"version":"build-2065373602"},"reference-count":117,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.trecan.2023.04.007","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T08:35:12Z","timestamp":1683707712000},"page":"666-678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thymic expression of immune checkpoint molecules and their implication for response to immunotherapies"],"prefix":"10.1016","volume":"9","author":[{"given":"Breanna","family":"Caruso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1952-7737","authenticated-orcid":false,"given":"Amy E.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2023.04.007_bb0005","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.3747\/co.27.5223","article-title":"A review of cancer immunotherapy: from the past, to the present, to the future","volume":"27","author":"Esfahani","year":"2020","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0010","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3389\/fimmu.2016.00550","article-title":"The PD1:PD-L1\/2 pathway from discovery to clinical implementation","volume":"7","author":"Bardhan","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0015","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev.immunol.19.1.565","article-title":"CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy","volume":"19","author":"Chambers","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0020","doi-asserted-by":"crossref","first-page":"9787","DOI":"10.1073\/pnas.96.17.9787","article-title":"A central role for thymic emigrants in peripheral T cell homeostasis","volume":"96","author":"Berzins","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2023.04.007_bb0025","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0167-5699(94)90174-0","article-title":"A differential-avidity model for T-cell selection","volume":"15","author":"Ashton-Rickardt","year":"1994","journal-title":"Immunol. Today"},{"key":"10.1016\/j.trecan.2023.04.007_bb0030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev.immunol.21.120601.141107","article-title":"Positive and negative selection of T cells","volume":"21","author":"Starr","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-immunol-020711-075035","article-title":"Selection of self-reactive T cells in the thymus","volume":"30","author":"Stritesky","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0040","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/ni.3751","article-title":"CD8\u03b1\u03b1 intraepithelial lymphocytes arise from two main thymic precursors","volume":"18","author":"Ruscher","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0045","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.4049\/jimmunol.151.4.1868","article-title":"Two signals are required for negative selection of CD4+CD8+ thymocytes","volume":"151","author":"Page","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/cimm.1998.1332","article-title":"Impaired negative selection in CD28-deficient mice","volume":"187","author":"Noel","year":"1998","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0055","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1084\/jem.179.2.709","article-title":"Negative selection of CD4+CD8+ thymocytes by T cell receptor-induced apoptosis requires a costimulatory signal that can be provided by CD28","volume":"179","author":"Punt","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.trecan.2023.04.007_bb0060","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/intimm\/8.12.1927","article-title":"CD28-B7 interactions function to co-stimulate clonal deletion of double-positive thymocytes","volume":"8","author":"Amsen","year":"1996","journal-title":"Int. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0065","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1615\/CritRevImmunol.2015012501","article-title":"CD28-CD80\/86 and CD40-CD40L interactions promote thymic tolerance by regulating medullary epithelial cell and thymocyte development","volume":"35","author":"Williams","year":"2015","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0070","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1182\/blood-2006-02-004531","article-title":"Developmental kinetics, turnover, and stimulatory capacity of thymic epithelial cells","volume":"108","author":"Gray","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2023.04.007_bb0075","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/intimm\/dxm095","article-title":"The aged thymus shows normal recruitment of lymphohematopoietic progenitors but has defects in thymic epithelial cells","volume":"19","author":"Gui","year":"2007","journal-title":"Int. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0080","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0161-5890(01)00122-5","article-title":"T cell receptor excision circle assessment of thymopoiesis in aging mice","volume":"38","author":"Sempowski","year":"2002","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0085","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/RTI.0000000000000349","article-title":"Age-stratified patterns of thymic involution on multidetector CT","volume":"33","author":"Drabkin","year":"2018","journal-title":"J. Thorac. Imaging"},{"key":"10.1016\/j.trecan.2023.04.007_bb0090","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/284555a0","article-title":"Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation","volume":"284","author":"Wyllie","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2023.04.007_bb0095","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1099\/jgv.0.000276","article-title":"NK-cells are involved in thymic atrophy induced by influenza A virus infection","volume":"96","author":"Duan","year":"2015","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0100","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.4049\/jimmunol.1200070","article-title":"Thymic function is maintained during Salmonella-induced atrophy and recovery","volume":"189","author":"Ross","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0105","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.4049\/jimmunol.1600934","article-title":"Sublethal total body irradiation causes long-term deficits in thymus function by reducing lymphoid progenitors","volume":"199","author":"Xiao","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0110","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2214\/ajr.149.2.269","article-title":"Thymic atrophy and regrowth in response to chemotherapy: CT evaluation","volume":"149","author":"Choyke","year":"1987","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.706244","article-title":"Thymus degeneration and regeneration","volume":"12","author":"Duah","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0120","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4049\/jimmunol.2200696","article-title":"Restored thymic output after androgen blockade participates in antitumor immunity","volume":"210","author":"Polesso","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0125","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.4049\/jimmunol.175.4.2741","article-title":"Activation of thymic regeneration in mice and humans following androgen blockade","volume":"175","author":"Sutherland","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0130","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1073\/pnas.0601040103","article-title":"Thymic output in aged mice","volume":"103","author":"Hale","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2023.04.007_bb0135","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.4049\/jimmunol.169.4.1984","article-title":"Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals","volume":"169","author":"Khan","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0140","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.4049\/jimmunol.174.11.7446","article-title":"The influence of age on T cell generation and TCR diversity","volume":"174","author":"Naylor","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0145","doi-asserted-by":"crossref","first-page":"B196","DOI":"10.1093\/gerona\/53A.3.B196","article-title":"Prevalence of CD8+ T-cell expansions in relation to age in healthy individuals","volume":"53","author":"Ricalton","year":"1998","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.trecan.2023.04.007_bb0150","doi-asserted-by":"crossref","first-page":"7759","DOI":"10.1128\/JVI.01262-06","article-title":"The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire","volume":"81","author":"Pourgheysari","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0155","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s13046-022-02566-0","article-title":"T-cell repertoire diversity: friend or foe for protective antitumor response?","volume":"41","author":"Porciello","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2023.04.007_bb0160","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.3390\/cancers14071771","article-title":"Evaluation of the TCR repertoire as a predictive and prognostic biomarker in cancer: diversity or clonality?","volume":"14","author":"Aran","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.trecan.2023.04.007_bb0165","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.amepre.2013.10.029","article-title":"Age and cancer risk: a potentially modifiable relationship","volume":"46","author":"White","year":"2014","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.trecan.2023.04.007_bb0170","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1073\/pnas.1714478115","article-title":"Thymic involution and rising disease incidence with age","volume":"115","author":"Palmer","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2023.04.007_bb0175","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/ijc.32145","article-title":"Characteristics and prognostic significance of profiling the peripheral blood T-cell receptor repertoire in patients with advanced lung cancer","volume":"145","author":"Liu","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.trecan.2023.04.007_bb0180","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.3389\/fimmu.2018.02729","article-title":"TCR repertoire as a novel indicator for immune monitoring and prognosis assessment of patients with cervical cancer","volume":"9","author":"Cui","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0185","article-title":"Characteristics and clinical significance of T-cell receptor repertoire in hepatocellular carcinoma","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0190","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.5396","article-title":"Characteristics, dynamic changes, and prognostic significance of TCR repertoire profiling in patients with renal cell carcinoma","volume":"251","author":"Guo","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2003352","article-title":"Capacity of tTreg generation is not impaired in the atrophied thymus","volume":"15","author":"Oh","year":"2017","journal-title":"PLoS Biol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0200","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12979-020-0173-8","article-title":"Contributions of age-related thymic involution to immunosenescence and inflammaging","volume":"17","author":"Thomas","year":"2020","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.trecan.2023.04.007_bb0205","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3389\/fimmu.2020.00773","article-title":"Thymic function associated with cancer development, relapse, and antitumor immunity - a mini-review","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0210","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semcancer.2005.11.005","article-title":"Regulatory T cells in immune surveillance and treatment of cancer","volume":"16","author":"Yamaguchi","year":"2006","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0215","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semcancer.2005.11.007","article-title":"Suppression of anti-cancer immunity by regulatory T cells: back to the future","volume":"16","author":"Orentas","year":"2006","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0220","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/ni.3150","article-title":"Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors","volume":"16","author":"Thiault","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0225","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13624","article-title":"Central tolerance is impaired in the middle-aged thymic environment","volume":"21","author":"Lancaster","year":"2022","journal-title":"Aging Cell"},{"key":"10.1016\/j.trecan.2023.04.007_bb0230","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000355303","article-title":"Regulatory T cells and the immune aging process: a mini-review","volume":"60","author":"Jagger","year":"2014","journal-title":"Gerontology"},{"key":"10.1016\/j.trecan.2023.04.007_bb0235","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3389\/fimmu.2013.00231","article-title":"The impact of aging on regulatory T-cells","volume":"4","author":"Fessler","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0240","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40425-015-0070-4","article-title":"Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma","volume":"3","author":"Postow","year":"2015","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.trecan.2023.04.007_bb0245","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.3389\/fimmu.2019.01336","article-title":"Clonality of CD4(+) blood T cells predicts longer survival with CTLA4 or PD-1 checkpoint inhibition in advanced melanoma","volume":"10","author":"Arakawa","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.752042","article-title":"Thymic function and T-cell receptor repertoire diversity: implications for patient response to checkpoint blockade immunotherapy","volume":"12","author":"Cardinale","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0255","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.trecan.2023.04.007_bb0260","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0265","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.715234","article-title":"CD8(+) T cell exhaustion in cancer","volume":"12","author":"Dolina","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0275","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature19330","article-title":"Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy","volume":"537","author":"Im","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2023.04.007_bb0280","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1(+)PD-1(+)CD8(+) T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.trecan.2023.04.007_bb0285","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1074-7613(02)00362-X","article-title":"The interaction properties of costimulatory molecules revisited","volume":"17","author":"Collins","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.trecan.2023.04.007_bb0290","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.4049\/jimmunol.1401876","article-title":"A transendocytosis model of CTLA-4 function predicts its suppressive behavior on regulatory T cells","volume":"194","author":"Hou","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106221","article-title":"CTLA-4: from mechanism to autoimmune therapy","volume":"80","author":"Hosseini","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0300","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1084\/jem.20082492","article-title":"Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies","volume":"206","author":"Peggs","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.trecan.2023.04.007_bb0305","first-page":"532","article-title":"The costimulatory molecule B7 is expressed in the medullary region of the murine thymus","volume":"81","author":"Reiser","year":"1994","journal-title":"Immunology"},{"key":"10.1016\/j.trecan.2023.04.007_bb0310","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.4049\/jimmunol.151.5.2453","article-title":"Medullary thymic epithelium expresses a ligand for CTLA4 in situ and in vitro","volume":"151","author":"Nelson","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0315","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1084\/jem.180.5.1849","article-title":"The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro","volume":"180","author":"Inaba","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.trecan.2023.04.007_bb0320","doi-asserted-by":"crossref","first-page":"17011","DOI":"10.1073\/pnas.1313001110","article-title":"Autoreactive thymic B cells are efficient antigen-presenting cells of cognate self-antigens for T cell negative selection","volume":"110","author":"Perera","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2023.04.007_bb0325","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.immuni.2015.05.013","article-title":"Thymic B cells are licensed to present self antigens for central T cell tolerance induction","volume":"42","author":"Yamano","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.trecan.2023.04.007_bb0330","doi-asserted-by":"crossref","first-page":"E221","DOI":"10.1073\/pnas.1208573110","article-title":"CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoire","volume":"110","author":"Verhagen","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2023.04.007_bb0335","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.4049\/jimmunol.152.7.3254","article-title":"B7 expression on thymic medullary epithelium correlates with epithelium-mediated deletion of V beta 5+ thymocytes","volume":"152","author":"Degermann","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0340","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/(SICI)1521-4141(199905)29:05<1598::AID-IMMU1598>3.0.CO;2-O","article-title":"Functional and phenotypic analysis of thymic B cells: role in the induction of T cell negative selection","volume":"29","author":"Ferrero","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0345","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1084\/jem.184.5.1631","article-title":"Rescue of thymocytes from glucocorticoid-induced cell death mediated by CD28\/CTLA-4 costimulatory interactions with B7-1\/B7-2","volume":"184","author":"Wagner","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.trecan.2023.04.007_bb0350","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1084\/jem.188.7.1239","article-title":"Cytotoxic T lymphocyte antigen 4 is induced in the thymus upon in vivo activation and its blockade prevents anti-CD3-mediated depletion of thymocytes","volume":"188","author":"Cilio","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.trecan.2023.04.007_bb0355","doi-asserted-by":"crossref","first-page":"9296","DOI":"10.1073\/pnas.94.17.9296","article-title":"Thymocyte development is normal in CTLA-4-deficient mice","volume":"94","author":"Chambers","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2023.04.007_bb0360","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<3137::AID-IMMU3137>3.0.CO;2-X","article-title":"Secondary but not primary T cell responses are enhanced in CTLA-4-deficient CD8+ T cells","volume":"28","author":"Chambers","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0365","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.4049\/jimmunol.163.5.2634","article-title":"The role of CTLA-4 in regulating Th2 differentiation","volume":"163","author":"Oosterwegel","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0370","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1002\/eji.1830270811","article-title":"Normal thymic selection, normal viability and decreased lymphoproliferation in T cell receptor-transgenic CTLA-4-deficient mice","volume":"27","author":"Waterhouse","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0375","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.4049\/jimmunol.170.11.5421","article-title":"A role for the B7-1\/B7-2:CD28\/CTLA-4 pathway during negative selection","volume":"170","author":"Buhlmann","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0380","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/eji.200324746","article-title":"In vivo overexpression of CTLA-4 suppresses lymphoproliferative diseases and thymic negative selection","volume":"35","author":"Takahashi","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0385","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.4049\/jimmunol.162.3.1294","article-title":"Timing and casting for actors of thymic negative selection","volume":"162","author":"Dautigny","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0390","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.4049\/jimmunol.173.11.6645","article-title":"Role of CTLA-4 in the activation of single- and double-positive thymocytes","volume":"173","author":"Kwon","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0395","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1073\/pnas.0803186106","article-title":"Enhanced selection of FoxP3+ T-regulatory cells protects CTLA-4-deficient mice from CNS autoimmune disease","volume":"106","author":"Verhagen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2023.04.007_bb0400","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4049\/jimmunol.149.2.380","article-title":"Identification and distribution of the costimulatory receptor CD28 in the mouse","volume":"149","author":"Gross","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0405","doi-asserted-by":"crossref","first-page":"E2383","DOI":"10.1073\/pnas.1603892113","article-title":"Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood","volume":"113","author":"Klocke","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2023.04.007_bb0410","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4049\/jimmunol.173.2.945","article-title":"SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation","volume":"173","author":"Chemnitz","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0415","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/j.1460-2075.1992.tb05481.x","article-title":"Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death","volume":"11","author":"Ishida","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.trecan.2023.04.007_bb0420","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/85330","article-title":"PD-L2 is a second ligand for PD-1 and inhibits T cell activation","volume":"2","author":"Latchman","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0425","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/intimm\/8.5.773","article-title":"Developmentally regulated expression of the PD-1 protein on the surface of double-negative (CD4-CD8-) thymocytes","volume":"8","author":"Nishimura","year":"1996","journal-title":"Int. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0430","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1084\/jem.191.5.891","article-title":"Facilitation of \u03b2 selection and modification of positive selection in the thymus of PD-1\u2013deficient mice","volume":"191","author":"Nishimura","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.trecan.2023.04.007_bb0435","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.febslet.2004.07.083","article-title":"PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70\/CD3zeta signalosome and downstream signaling to PKCtheta","volume":"574","author":"Sheppard","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.trecan.2023.04.007_bb0440","doi-asserted-by":"crossref","first-page":"9543","DOI":"10.1128\/MCB.25.21.9543-9553.2005","article-title":"CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms","volume":"25","author":"Parry","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0445","doi-asserted-by":"crossref","first-page":"ra46","DOI":"10.1126\/scisignal.2002796","article-title":"Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation","volume":"5","author":"Patsoukis","year":"2012","journal-title":"Sci. Signal."},{"key":"10.1016\/j.trecan.2023.04.007_bb0450","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201905085","article-title":"PD-1 and BTLA regulate T cell signaling differentially and only partially through SHP1 and SHP2","volume":"219","author":"Xu","year":"2020","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0455","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-065X.2009.00767.x","article-title":"PD-1 signaling in primary T cells","volume":"229","author":"Riley","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.trecan.2023.04.007_bb0460","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1073\/pnas.0712278105","article-title":"The PD-1\/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors","volume":"105","author":"Lin","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2023.04.007_bb0465","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/intimm\/dxq049","article-title":"PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1","volume":"22","author":"Ghiotto","year":"2010","journal-title":"Int. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0470","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0165-2478(02)00142-6","article-title":"Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues","volume":"84","author":"Ishida","year":"2002","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.trecan.2023.04.007_bb0475","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1002\/eji.200324228","article-title":"Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses","volume":"33","author":"Liang","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0480","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.4049\/jimmunol.170.3.1257","article-title":"Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production","volume":"170","author":"Brown","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0485","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.4049\/jimmunol.1700768","article-title":"CD40 mediates maturation of thymic dendritic cells driven by self-reactive CD4(+) thymocytes and supports development of natural regulatory T cells","volume":"200","author":"Oh","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0490","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1074-7613(00)80089-8","article-title":"Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor","volume":"11","author":"Nishimura","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.trecan.2023.04.007_bb0495","doi-asserted-by":"crossref","first-page":"7372","DOI":"10.4049\/jimmunol.175.11.7372","article-title":"Programmed death-1 (PD-1):PD-ligand 1 interactions inhibit TCR-mediated positive selection of thymocytes","volume":"175","author":"Keir","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0500","doi-asserted-by":"crossref","first-page":"837","DOI":"10.4049\/jimmunol.179.2.837","article-title":"Transcriptional analysis of clonal deletion in vivo","volume":"179","author":"Baldwin","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0505","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/intimm\/dxg125","article-title":"Gene expression analysis of thymocyte selection in vivo","volume":"15","author":"Schmitz","year":"2003","journal-title":"Int. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0510","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.immuni.2005.01.015","article-title":"Defective central tolerance induction in NOD mice: genomics and genetics","volume":"22","author":"Zucchelli","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.trecan.2023.04.007_bb0515","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/gb-2007-8-1-r12","article-title":"Impairment of organ-specific T cell negative selection by diabetes susceptibility genes: genomic analysis by mRNA profiling","volume":"8","author":"Liston","year":"2007","journal-title":"Genome Biol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0520","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaut.2011.02.009","article-title":"Programmed death-1 is required for systemic self-tolerance in newly generated T cells during the establishment of immune homeostasis","volume":"36","author":"Thangavelu","year":"2011","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.trecan.2023.04.007_bb0525","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1002\/eji.201444688","article-title":"PD-1 is not required for natural or peripherally induced regulatory T cells: severe autoimmunity despite normal production of regulatory T cells","volume":"44","author":"Ellestad","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0530","first-page":"259","article-title":"Rag defects and thymic stroma: lessons from animal models","volume":"5","author":"Marrella","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0535","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1002\/eji.201344423","article-title":"PD-1 regulates extrathymic regulatory T-cell differentiation","volume":"44","author":"Chen","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0540","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1126\/science.1233913","article-title":"Aire-dependent thymic development of tumor-associated regulatory T cells","volume":"339","author":"Malchow","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.trecan.2023.04.007_bb0545","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ni944","article-title":"BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1","volume":"4","author":"Watanabe","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0550","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/ni1144","article-title":"B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator","volume":"6","author":"Sedy","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0555","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.4049\/jimmunol.172.10.5931","article-title":"An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection","volume":"172","author":"Han","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0560","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.immuni.2013.10.017","article-title":"The inhibitory receptor BTLA controls \u03b3\u03b4 T cell homeostasis and inflammatory responses","volume":"39","author":"Bekiaris","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.trecan.2023.04.007_bb0565","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1084\/jem.20100619","article-title":"VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses","volume":"208","author":"Wang","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.trecan.2023.04.007_bb0570","doi-asserted-by":"crossref","first-page":"eaay0524","DOI":"10.1126\/science.aay0524","article-title":"VISTA is a checkpoint regulator for na\u00efve T cell quiescence and peripheral tolerance","volume":"367","author":"ElTanbouly","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.trecan.2023.04.007_bb0575","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.3389\/fimmu.2018.02374","article-title":"Inhibitory receptors and pathways of lymphocytes: the role of PD-1 in Treg development and their involvement in autoimmunity onset and cancer progression","volume":"9","author":"Gianchecchi","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2023.04.007_bb0580","doi-asserted-by":"crossref","first-page":"vii7","DOI":"10.1093\/rheumatology\/kez418","article-title":"Toxicities associated with checkpoint inhibitors-an overview","volume":"58","author":"Spiers","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.trecan.2023.04.007_bb0585","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/ni1008-1091","article-title":"The immunological genome project: networks of gene expression in immune cells","volume":"9","author":"Heng","year":"2008","journal-title":"Nat. Immunol."}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803323000638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803323000638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:57:46Z","timestamp":1762505866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405803323000638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":117,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2405803323000638"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2023.04.007","relation":{},"ISSN":["2405-8033"],"issn-type":[{"type":"print","value":"2405-8033"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thymic expression of immune checkpoint molecules and their implication for response to immunotherapies","name":"articletitle","label":"Article Title"},{"value":"Trends in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trecan.2023.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}